Medical

Whole Blood

Donor blood containing all components (red cells, plasma, platelets, white cells) in their natural physiologic ratios, in contrast to component therapy which separates these for individual storage. Whole blood is the TCCC-preferred resuscitation fluid for hemorrhagic shock, particularly cold-stored low-titer O whole blood (LTOWB), which can be transfused as a universal donor product without crossmatch.

In the Field
Whole blood is what changed forward trauma resuscitation. For decades, component therapy was the standard in civilian and military medicine - blood was separated into red cells, plasma, and platelets, each stored separately. The Vietnam and Iraq experience demonstrated that whole blood transfused in physiologic ratios produced better outcomes than reconstructed component therapy in trauma. The operational rollout of cold-stored low-titer O whole blood through programs like the Trauma Hemostasis and Oxygenation Research (THOR) Network and Armed Services Blood Program has put whole blood forward of role 2 in many tactical settings. TCCC 2026 lists cold-stored low-titer O whole blood as the most preferred resuscitation fluid for hemorrhagic shock.
Common Mistake
Treating whole blood like component products. Storage temperatures, shelf life, and compatibility considerations differ. Cold-stored LTOWB has a 21 to 35 day shelf life (depending on anticoagulant) at 1 to 6 degrees C. Pre-screened low-titer O fresh whole blood from walking blood banks has a much shorter window but no refrigeration requirement during the donation-to-transfusion interval. The other mistake is forgetting that whole blood does not replace surgical hemorrhage control. Whole blood maintains the casualty during evacuation; it does not stop the bleeding. The surgical team at the next level of care is the definitive intervention.

Technical Detail

Whole blood composition: approximately 450 mL of donor blood plus anticoagulant (CPDA-1, CPD, or others), containing red cells (hematocrit approximately 35 to 45 percent), plasma (about 250 mL), platelets (variable concentration depending on storage), white cells (often filtered out). Cold-stored low-titer O whole blood (LTOWB): O-type donor blood pre-screened for low titers of anti-A and anti-B antibodies, allowing transfusion to non-O recipients with minimal hemolytic reaction risk. Storage: 1 to 6 degrees C; shelf life 21 to 35 days. Pre-screened low-titer O fresh whole blood: donor pool of pre-screened personnel donating during operational need (walking blood bank); no refrigerated storage; immediate use. TCCC 2026 fluid resuscitation hierarchy: (1) cold-stored low-titer O whole blood; (2) pre-screened low-titer O fresh whole blood; (3) plasma, RBCs, and platelets in 1:1:1 ratio; (4) plasma and RBCs in 1:1 ratio; (5) plasma or RBCs alone. Calcium replacement (1 g calcium gluconate or 10 mL 10 percent calcium chloride) is administered IV/IO after the first unit transfused due to citrate-induced hypocalcemia. Reassess after each unit; continue until palpable radial pulse, improved mental status, or SBP of 100 mmHg.